|
||
Accolades
|
Area of Expertise: Transport and Signaling
Director, Carnegie Institution for Science, Stanford
Adjunct Professor, Department Biological Science, Stanford University
PI on an NSF 2010 project to test all membrane protein-protein interactions in Arabidopsis using a two-hybrid system. This project is synergistic with the proposed subproject on identifying the protein complexes involving carbohydrate-active enzymes by direct purification of the complexes. Also a PI on a multi-investigator NIH project focused on developing nanosensors for a wide range of biologically relevant metabolites. This technology may be very useful for measuring the release of sugars from biomass by modified enzymes in real time. Head of research program that is focused on identifying and characterizing metabolites transporters. This program is synergistic with the proposed investigation of how lignin monomers are secreted and also with prosed experiments designed to develop transporters that lead to secretion of alkanes or long-chain alcohols by microbial cells.
* Founder of the biotechnology company SYMPORE GmbH, Tübingen (2000-2004)
* Scientific Advisor to SYMPORE GmbH (2000-2002)
* Business Advisory Board Member SYMPORE GmbH (2001-2002)
Advisory Board of the Joint Bioenergy Institute, Emeryville
Head Plant Biochemistry Section Faculty of 1000
Area of Expertise: Transport and Signaling
How does agricultural biotechnology contribute to solving the world's need for more food, water, and fuels?
Agricultural biotechnology is essential for the development of novel crops that are needed urgently to address the effects of global warming, limited food supply and the requirement of biofuels.
Why should the public and policymakers care about agricultural biotechnology?
The most pressing global issues such as provision of adequate food supply can only be addressed by a combination of new policies and innovation through agricultural biotechnology.
Where will the field of agricultural biotechnology be in 10 years?
The success of the field can only be achieved with extensive funding of basic research, at a level similar as medical research.